Section one: Contracting authority
one.1) Name and addresses
NHS England
7-8 Wellington Place
Leeds
LS1 4AP
Contact
Andrew Wilson
Country
United Kingdom
Region code
UKE - Yorkshire and the Humber
Internet address(es)
Main address
Buyer's address
one.3) Communication
Additional information can be obtained from the above-mentioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at
https://health-family.force.com/s/Welcome
one.4) Type of the contracting authority
Ministry or any other national or federal authority
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
NHS England Continuous Glucose Monitoring and Insulin Pen Needles RFI
Reference number
C305527
two.1.2) Main CPV code
- 33190000 - Miscellaneous medical devices and products
two.1.3) Type of contract
Supplies
two.1.4) Short description
NHS England is undertaking a Request for Information (RFI) exercise to explore the availability and supply of Continuous Glucose Monitoring (CGM) devices and Insulin Pen Needles. The aim of this Request for Information is to gather relevant information from suppliers in the market to better understand current offerings, innovations, and potential solutions that can support effective diabetes management in NHS services.
This exercise is purely for information gathering purposes and does not constitute a formal procurement process. However, the information provided will assist NHS England in shaping potential future procurement strategies and ensuring that patients benefit from high-quality and cost-effective products.
Key Areas of Interest:
- The range of Continuous Glucose Monitoring devices available.
- Features and benefits of CGM systems, including accuracy, ease of use, and connectivity with other diabetes management tools.
- Insulin Pen Needles, including size, comfort, safety features, and availability of various gauges.
- Innovations in the field of diabetes care, including new products or technologies.
- Supplier capabilities, including delivery, support, and potential cost efficiencies.
Suppliers with relevant products and services in these areas are encouraged to participate in the Request for Information process
This PIN is for market engagement purposes only. Participation in this Request for Information does not constitute any offer or guarantee of future procurement, and it does not imply that a contract or tender will follow.
Providers wishing to provide information will need to respond with the information requested by the documentation and submit responses prior to the deadline stated in this notice. The RFI documentation including a questionnaire is available through the Atamis (Health Family) portal: https://health-family.force.com/s/Welcome. The reference is C305527 and the closing date for completed RFI responses is 17:00pm , on Wednesday 18th September 2024. To express interest and participate in this request for information exercise, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should
Providers have any queries, or having problems using the portal, they should contact
Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk
two.1.5) Estimated total value
Value excluding VAT: £215,000,000
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.2) Additional CPV code(s)
- 33615000 - Medicinal products used in diabetes
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
Main site or place of performance
England
two.2.4) Description of the procurement
Assessment of Drug Tariff medical devices used in the management of diabetes
two.2.14) Additional information
This PIN is for market engagement purposes only. Participation in this Request for Information does not constitute any offer or guarantee of future procurement, and it does not imply that a contract or tender will follow.
two.3) Estimated date of publication of contract notice
1 October 2024
Section four. Procedure
four.1) Description
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes